Evaluating the role of race and medication in protection of uterine fibroids by type 2 diabetes exposure.

MLA

Edwards, Digna R.Velez, et al. “Evaluating the Role of Race and Medication in Protection of Uterine Fibroids by Type 2 Diabetes Exposure.” BMC Women’s Health, vol. 17, Apr. 2017, pp. 1–6. EBSCOhost, https://doi.org/10.1186/s12905-017-0386-y.

APA

Edwards, D. R. V., Hartmann, K. E., Wellons, M., Shah, A., Hua Xu, Edwards, T. L., Velez Edwards, D. R., & Xu, H. (2017). Evaluating the role of race and medication in protection of uterine fibroids by type 2 diabetes exposure. BMC Women’s Health, 17, 1–6. https://doi.org/10.1186/s12905-017-0386-y

Chicago

Edwards, Digna R. Velez, Katherine E. Hartmann, Melissa Wellons, Anushi Shah, Hua Xu, Todd L. Edwards, Digna R Velez Edwards, and Hua Xu. 2017. “Evaluating the Role of Race and Medication in Protection of Uterine Fibroids by Type 2 Diabetes Exposure.” BMC Women’s Health 17 (April): 1–6. doi:10.1186/s12905-017-0386-y.